Alaunos Therapeutics Inc (TCRT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.16
• Market Cap: $6.99M
• EPS: $-2.53
• 52-Week High: $5.48
• 52-Week Low: $1.31

About Alaunos Therapeutics Inc

Alaunos Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Houston, Texas, dedicated to advancing innovative immuno-oncology therapies for cancer treatment. With a strong focus on developing its proprietary T Cell Receptor (TCR) therapy platform, Alaunos aims to harness the power of the immune system to provide effective, targeted therapies for patients with solid tumors. As it continues to progress through clinical trials, the company is positioned to play a sig...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Alaunos Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TCRT pay dividends?

Alaunos Therapeutics Inc (TCRT) does not currently pay a regular dividend.

What is TCRT's market cap?

Alaunos Therapeutics Inc (TCRT) has a market capitalization of $6.99M with a current stock price of $3.16.